Strikingly, although we observed that linifanib could inhibit miR-10b, its anti-cancer effects were simultaneously reduced when miR-10b levels were high since high miR-10b inhibited linifanib’s interaction with VEGFR and PDGFR. This evidence concerns the gene PDGFRB and cancer.